Literature DB >> 20129639

Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes.

Michael J Lace1, James R Anson, Thomas H Haugen, Lubomir P Turek.   

Abstract

Interferon regulatory factors (IRFs) are critical mediators of gene expression, cell growth and immune responses. We previously demonstrated that interferon (IFN) induction of early viral transcription and replication in several mucosal HPVs requires IRF-1 binding to a conserved interferon response element (IRE). Here we show that the IRF-2 protein serves as a baseline transactivator of the HPV-16 major early promoter, P97. Cotransfections in IRF knockout cells confirmed that basal HPV-16 promoter activity was supported by both IRF-1 and IRF-2 complexes interacting with the promoter-proximal IRE in a dose-dependent manner. Furthermore, HPV-16 E7 expression downregulates the IRF-2 promoter, thus linking IRF-2 levels to viral transforming gene expression through a negative feedback mechanism. Taken together, these observations reveal a complex viral strategy utilizing multiple signal transduction pathways during the establishment and maintenance of HPV persistence. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20129639     DOI: 10.1016/j.virol.2009.12.025

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

Review 1.  Manipulation of the innate immune response by human papillomaviruses.

Authors:  Shiyuan Hong; Laimonis A Laimins
Journal:  Virus Res       Date:  2016-11-05       Impact factor: 3.303

Review 2.  Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.

Authors:  Abhik Saha; Rajeev Kaul; Masanao Murakami; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2010-11-15       Impact factor: 4.742

3.  Site-directed mutagenesis of human papillomavirus 18 promoter elements and tissue-specific expression in cervical carcinoma cells.

Authors:  Mandy S Y Lung; Ning Zhang; Vincent Murray
Journal:  Virus Genes       Date:  2012-02-21       Impact factor: 2.332

4.  Regulation of CEACAM1 transcription in human breast epithelial cells.

Authors:  Marieta Gencheva; Charng-Jui Chen; Tung Nguyen; John E Shively
Journal:  BMC Mol Biol       Date:  2010-11-04       Impact factor: 2.946

5.  The simian immunodeficiency virus targets central cell cycle functions through transcriptional repression in vivo.

Authors:  Carl-Magnus Hogerkorp; Yoshiaki Nishimura; Kaimei Song; Malcolm A Martin; Mario Roederer
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

6.  Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum.

Authors:  Pei-Song Gao; Donald Y M Leung; Nicholas M Rafaels; Mark Boguniewicz; Tracey Hand; Li Gao; Tissa R Hata; Lynda C Schneider; Jon M Hanifin; Terri H Beaty; Lisa A Beck; Adriana Weinberg; Kathleen C Barnes
Journal:  J Invest Dermatol       Date:  2011-11-24       Impact factor: 8.551

Review 7.  The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.

Authors:  Lifang Zhang; Jianhong Wu; Ming Tat Ling; Liang Zhao; Kong-Nan Zhao
Journal:  Mol Cancer       Date:  2015-04-17       Impact factor: 27.401

8.  A systems biology analysis of the changes in gene expression via silencing of HPV-18 E1 expression in HeLa cells.

Authors:  Andres Castillo; Lu Wang; Chihaya Koriyama; Yoshito Eizuru; King Jordan; Suminori Akiba
Journal:  Open Biol       Date:  2014-10       Impact factor: 6.411

Review 9.  Interferon regulatory factor 1 inactivation in human cancer.

Authors:  Khaldoon Alsamman; Omar S El-Masry
Journal:  Biosci Rep       Date:  2018-05-08       Impact factor: 3.840

10.  The use of a human papillomavirus 18 promoter for tissue-specific expression in cervical carcinoma cells.

Authors:  Mandy S Y Lung; Wendy M Mak; Vincent Murray
Journal:  Cell Mol Biol Lett       Date:  2011-07-18       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.